Allergan plc Insider Trading for May 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allergan plc for May 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2014 | AGN | Allergan plc | PAONESSA ALBERT III | President Anda, Inc ... | Grant | A | 197.05 | 1,269 | 250,056 | 28,498 | 27.2 K to 28.5 K (+4.66 %) |
May 13 2014 | AGN | Allergan plc | Mayr Charles M | Chief Communic Off- ... | Grant | A | 197.05 | 1,692 | 333,409 | 13,088 | 11.4 K to 13.1 K (+14.85 %) |
May 13 2014 | AGN | Allergan plc | BUCHEN DAVID A | Chief Legal Officer ... | Grant | A | 197.05 | 2,960 | 583,268 | 62,926 | 60 K to 62.9 K (+4.94 %) |
May 13 2014 | AGN | Allergan plc | Stewart Robert A | Pres-Global Operati ... | Grant | A | 197.05 | 3,383 | 666,620 | 44,636 | 41.3 K to 44.6 K (+8.20 %) |
May 13 2014 | AGN | Allergan plc | BISARO PAUL | Chair,Pres &CEO | Grant | A | 197.05 | 10,150 | 2,000,058 | 410,145 | 400 K to 410.1 K (+2.54 %) |
May 13 2014 | AGN | Allergan plc | WEISS FRED G | Director | Grant | A | 197.05 | 1,142 | 225,031 | 25,417 | 24.3 K to 25.4 K (+4.70 %) |
May 13 2014 | AGN | Allergan plc | TURNER ANDREW L | Director | Grant | A | 197.05 | 1,142 | 225,031 | 1,142 | 0 to 1.1 K |
May 13 2014 | AGN | Allergan plc | TAYLOR RONALD R | Director | Grant | A | 197.05 | 1,142 | 225,031 | 23,084 | 21.9 K to 23.1 K (+5.20 %) |
May 13 2014 | AGN | Allergan plc | JOYCE R TODD | CFO-Global | Grant | A | 197.05 | 2,537 | 499,916 | 2,537 | 0 to 2.5 K |
May 13 2014 | AGN | Allergan plc | O'Sullivan Patrick J | Director | Grant | A | 197.05 | 1,142 | 225,031 | 3,412 | 2.3 K to 3.4 K (+50.31 %) |
May 13 2014 | AGN | Allergan plc | Michal Jiri | Director | Grant | A | 197.05 | 1,839 | 362,375 | 1,839 | 0 to 1.8 K |
May 13 2014 | AGN | Allergan plc | KLEMA CATHY | Director | Grant | A | 197.05 | 1,142 | 225,031 | 20,750 | 19.6 K to 20.8 K (+5.82 %) |
May 13 2014 | AGN | Allergan plc | KING JOHN A | Director | Grant | A | 197.05 | 1,142 | 225,031 | 65,789 | 64.6 K to 65.8 K (+1.77 %) |
May 13 2014 | AGN | Allergan plc | HOWSON TAMAR D | Director | Grant | A | 197.05 | 1,142 | 225,031 | 2,088 | 946 to 2.1 K (+120.72 %) |
May 13 2014 | AGN | Allergan plc | BODINE CHRIS W | Director | Grant | A | 197.05 | 1,142 | 225,031 | 12,771 | 11.6 K to 12.8 K (+9.82 %) |
May 13 2014 | AGN | Allergan plc | BLOEM JAMES H | Director | Grant | A | 197.05 | 1,142 | 225,031 | 8,942 | 7.8 K to 8.9 K (+14.64 %) |
May 13 2014 | AGN | Allergan plc | Fridriksdottir Hafrun | SVP, GLOBAL R&D | Grant | A | 197.05 | 1,269 | 250,056 | 6,914 | 5.6 K to 6.9 K (+22.48 %) |
May 13 2014 | AGN | Allergan plc | DArecca James | VP, CHIEF ACCOUNTIN ... | Grant | A | 197.05 | 338 | 66,603 | 338 | 0 to 338 |